Page last updated: 2024-10-31

monodansylcadaverine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

monodansylcadaverine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

monodansylcadaverine: inhibits cross linkage of fibrin
monodansylcadaverine : A sulfonamide obtained by formal condensation of the sulfo group of 5-(dimethylamino)naphthalene-1-sulfonic acid with one of the amino groups of cadaverine.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, S1
Pridham, KJ1
Virbasius, CM1
He, B1
Zhang, L1
Varmark, H1
Green, MR1
Sheng, Z1

Other Studies

1 other study available for monodansylcadaverine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
A large-scale RNA interference screen identifies genes that regulate autophagy at different stages.
    Scientific reports, 2018, 02-12, Volume: 8, Issue:1

    Topics: Apoptosis Regulatory Proteins; Autophagy; Cadaverine; Cell Line, Tumor; Drug Resistance, Neoplasm; F

2018